Log in to save to my catalogue

Supraphysiologic doses of 17[beta]-estradiol aggravate depression-like behaviors in ovariectomized m...

Supraphysiologic doses of 17[beta]-estradiol aggravate depression-like behaviors in ovariectomized m...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A763994124

Supraphysiologic doses of 17[beta]-estradiol aggravate depression-like behaviors in ovariectomized mice possibly via regulating microglial responses and brain glycerophospholipid metabolism

About this item

Full title

Supraphysiologic doses of 17[beta]-estradiol aggravate depression-like behaviors in ovariectomized mice possibly via regulating microglial responses and brain glycerophospholipid metabolism

Publisher

BioMed Central Ltd

Journal title

Journal of neuroinflammation, 2023-09, Vol.20 (1)

Language

English

Formats

Publication information

Publisher

BioMed Central Ltd

More information

Scope and Contents

Contents

Background 17[beta]-Estradiol (E2) is generally considered neuroprotective in humans. However, the current clinical use of estrogen replacement therapy (ERT) is based on the physiological dose of E2 to treat menopausal syndrome and has limited therapeutic efficacy. The efficacy and potential toxicity of superphysiological doses of ERT for menopausa...

Alternative Titles

Full title

Supraphysiologic doses of 17[beta]-estradiol aggravate depression-like behaviors in ovariectomized mice possibly via regulating microglial responses and brain glycerophospholipid metabolism

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A763994124

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A763994124

Other Identifiers

ISSN

1742-2094

E-ISSN

1742-2094

DOI

10.1186/s12974-023-02889-5

How to access this item